Barclays analyst Jiong Shao lowered the firm’s price target on Meituan (MPNGF) to $15 from $16 and keeps an Underweight rating on the shares. The company’s Q1 results were ahead of expectations, with “especially strong beats” in margins and profits, the analyst tells investors in a research note. However, the firm says intensifying competition and renewed regulatory scrutiny are creating overhang on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MPNGF:
- Meituan’s Strong Financial Performance and Strategic Initiatives Justify Buy Rating Amid Global Expansion
- Meituan’s Earnings Call: Growth Amidst Challenges
- Meituan Dianping Reports Strong Q1 2025 Growth
- Meituan Reports Strong Q1 2025 Financial Performance
- Meituan Strengthens Governance with New Nomination Committee Appointment